Vyaire Medical chief executive officer Gaurav Agarwal was recently interviewed by McKinsey about the Vyaire Medical team’s dedicated efforts to ramp up production and meet patient needs in response to COVID-19.
Normally, joining a company to oversee more than half of its worldwide employees is a big challenge. Add a global pandemic to the mix and suddenly that task is amplified tremendously.
“I can’t breathe.” Like so many of you, I’m nauseated when I see the images of George Floyd’s murder—to watch the humanity and life be stripped from him as he struggles to say those words. “I can’t breathe.”
Vyaire Medical employees have been doing whatever they can to meet the unprecedented demand for respiratory equipment for treating COVID-19 patients, not only expanding efforts in their normal roles, but also pitching in to help other departments. They’re also there to help one another.
Vyaire Medical continues to work on two fronts to have positive impacts on the health and lives of patients worldwide.
Vyaire Medical knows there’s more to increasing production to meet the increasing worldwide demand for ventilators than procuring resources and protecting the supply chain. A top priority has been – and remains – the health and safety of all employees worldwide.
Vyaire Medical Inc., the world’s largest healthcare company fully dedicated to respiratory care, has undertaken several corporate initiatives in its continuing efforts to support the global healthcare community in its fight against the COVID-19 pandemic.
Vyaire Medical Inc., the world’s largest healthcare company fully dedicated to respiratory care, has started shipping its LTV2 2200 ventilators as part of its contract with the U.S. Department of Health and Human Services (HHS).
Vyaire Medical’s field service technicians have been keeping up with the increased customer demand for ventilator installations and maintenance thanks to a little help from their friends, both inside and outside the company.